NO305122B1 - AnalogifremgangsmÕte ved fremstilling av kinolin-, naftyridin- og pyridobenzoksazinderivater - Google Patents

AnalogifremgangsmÕte ved fremstilling av kinolin-, naftyridin- og pyridobenzoksazinderivater

Info

Publication number
NO305122B1
NO305122B1 NO932176A NO932176A NO305122B1 NO 305122 B1 NO305122 B1 NO 305122B1 NO 932176 A NO932176 A NO 932176A NO 932176 A NO932176 A NO 932176A NO 305122 B1 NO305122 B1 NO 305122B1
Authority
NO
Norway
Prior art keywords
naphthyridine
quinoline
preparation
analogous process
pyridobenzoxazine derivatives
Prior art date
Application number
NO932176A
Other languages
English (en)
Norwegian (no)
Other versions
NO932176L (no
NO932176D0 (no
Inventor
Daniel T Chu
Curt S Cooper
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO932176L publication Critical patent/NO932176L/no
Publication of NO932176D0 publication Critical patent/NO932176D0/no
Publication of NO305122B1 publication Critical patent/NO305122B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO932176A 1990-12-12 1993-06-14 AnalogifremgangsmÕte ved fremstilling av kinolin-, naftyridin- og pyridobenzoksazinderivater NO305122B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/626,602 US5137892A (en) 1990-12-12 1990-12-12 Quinoline, naphthyridine and pyridobenzoxazine derivatives
PCT/US1991/009419 WO1992010191A1 (en) 1990-12-12 1991-12-12 Quinoline, naphthyridine and pyridobenzoxazine derivatives

Publications (3)

Publication Number Publication Date
NO932176L NO932176L (no) 1993-06-14
NO932176D0 NO932176D0 (no) 1993-06-14
NO305122B1 true NO305122B1 (no) 1999-04-06

Family

ID=24511084

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932176A NO305122B1 (no) 1990-12-12 1993-06-14 AnalogifremgangsmÕte ved fremstilling av kinolin-, naftyridin- og pyridobenzoksazinderivater

Country Status (8)

Country Link
US (1) US5137892A (zh)
EP (1) EP0562042A4 (zh)
JP (1) JP2546769B2 (zh)
AU (1) AU9175991A (zh)
IE (1) IE914115A1 (zh)
NO (1) NO305122B1 (zh)
TW (1) TW230774B (zh)
WO (1) WO1992010191A1 (zh)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
US5541155A (en) * 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US6099856A (en) 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
US5578323A (en) * 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US5629020A (en) 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5693338A (en) 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US5443841A (en) * 1992-06-15 1995-08-22 Emisphere Technologies, Inc. Proteinoid microspheres and methods for preparation and use thereof
KR100232937B1 (ko) * 1991-05-28 1999-12-01 스즈키 다다시 피리돈카복실산 유도체 및 이를 함유하는 항균제
US5412098A (en) * 1991-12-27 1995-05-02 Wakunaga Seiyaku Kabushiki Kaisha Quinolone derivative or salt thereof and antibacterial containing the same
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5811127A (en) 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
DE4232172A1 (de) * 1992-09-25 1994-03-31 Bayer Ag 7-(Aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)chinolon- und Naphthyridoncarbonsäure-Derivate
WO1994008967A1 (en) * 1992-10-09 1994-04-28 Chugai Seiyaku Kabushiki Kaisha Fluoroquinoline derivative
US5401516A (en) * 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
EP0621267A1 (en) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidine derivatives and their use as fungicides
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
EP1025840B1 (en) 1993-04-22 2005-06-29 Emisphere Technologies, Inc. Oral drug compositions
US5958457A (en) 1993-04-22 1999-09-28 Emisphere Technologies, Inc. Compositions for the delivery of antigens
TW252107B (zh) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
WO1996022988A1 (fr) * 1995-01-24 1996-08-01 Hokuriku Seiyaku Co., Ltd. Derives de l'acide quiloleine carboxylique
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CN1151836C (zh) 1995-03-31 2004-06-02 艾米斯菲尔技术有限公司 用作传送活性剂的化合物和组合物
US6090958A (en) 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5989539A (en) 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5965121A (en) 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5820881A (en) 1995-04-28 1998-10-13 Emisphere Technologies, Inc. Microspheres of diamide-dicarboxylic acids
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US5824345A (en) 1995-06-07 1998-10-20 Emisphere Technologies, Inc. Fragrances and flavorants
US5667806A (en) 1995-06-07 1997-09-16 Emisphere Technologies, Inc. Spray drying method and apparatus
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
GB2320248B (en) 1995-09-11 1999-04-14 Emisphere Tech Inc Method for preparing omega-aminoalkanoic acid derivatives from cycloalkanones
WO1997047288A1 (en) 1996-06-14 1997-12-18 Emisphere Technologies, Inc. Microencapsulated fragrances and method for preparation
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US5990166A (en) 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5876710A (en) 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US5804688A (en) 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6060513A (en) 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5939381A (en) 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6133307A (en) * 1997-04-30 2000-10-17 Warner-Lambert Company Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonists
US5863944A (en) 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
KR100286874B1 (ko) * 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
US8163769B2 (en) * 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
WO2004083207A1 (en) * 2003-03-12 2004-09-30 Abbott Laboratories Naphthyridine derivatives as antibacterial agents
JP4639149B2 (ja) * 2003-09-10 2011-02-23 杏林製薬株式会社 7−(4−置換−3−シクロプロピルアミノメチル−1−ピロリジニル)キノロンカルボン酸誘導体
US7977346B2 (en) * 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
WO2008143343A1 (ja) * 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5872589A (ja) * 1981-10-28 1983-04-30 Dai Ichi Seiyaku Co Ltd ピリド〔1,2,3−de〕〔1,4〕ベンゾオキサジン誘導体
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4929613A (en) * 1987-08-26 1990-05-29 Warner-Lambert Company Antibacterial agents
DE3814517A1 (de) * 1988-02-05 1989-08-17 Bayer Ag Chinolon- und naphthyridoncarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende antibakterielle mittel und futterzusatzstoffe
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
JPH04502317A (ja) * 1988-12-06 1992-04-23 ジ・アップジョン・カンパニー 抗菌性キノロン化合物
US5276041A (en) * 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives

Also Published As

Publication number Publication date
US5137892A (en) 1992-08-11
JP2546769B2 (ja) 1996-10-23
EP0562042A1 (en) 1993-09-29
TW230774B (zh) 1994-09-21
EP0562042A4 (en) 1994-07-06
IE914115A1 (en) 1992-06-17
JPH05508868A (ja) 1993-12-09
NO932176L (no) 1993-06-14
WO1992010191A1 (en) 1992-06-25
AU9175991A (en) 1992-07-08
NO932176D0 (no) 1993-06-14

Similar Documents

Publication Publication Date Title
NO305122B1 (no) AnalogifremgangsmÕte ved fremstilling av kinolin-, naftyridin- og pyridobenzoksazinderivater
NO864247L (no) Fremgangsmaate ved fremstilling av quinolinderivater.
NO885106D0 (no) FremgangsmŸte ved fremstilling av cytidin-derivater.
NO914809L (no) Fremgangsmaate ved fremstilling av celluloseformlegemer
YU27788A (en) Process for obtaining quinoline derivatives
NO180084C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO880068D0 (no) Fremgangsmaate ved fremstilling av heteroaryl-3-okso-propannitrilderivater.
ZA82740B (en) Novel sesquihydrate of naphthyridine derivative,and process for the preparation thereof
NO883392D0 (no) Fremgangsmaate ved fremstilling av tiometyl- og sulfinylmetylderivater.
ZA915567B (en) Process for the manufacture of quinoline derivatives
IL104137A (en) Process for the manufacture of 2-alkoxymethylacrolein compounds, their use for preparing 3-alkoxymethyl quinolines and 3-alkoxymethyl quinoline compounds
NO179517C (no) Fremgangsmåte for fremstilling av 8-klorkinolonderivater
NO882528L (no) Fremgangsmaate ved fremstilling av 2-metoksymetyl-penem-derivater.
HUP9900739A3 (en) Process for the preparation of quinoline derivatives, and the intermediates
HU901554D0 (en) Process for the preparation of quinoline derivatives
NO943071L (no) Fremgangsmåte ved fremstilling av 2,3,5,6-tetraklorpyridin
GB2051065B (en) Process for the preparation of indoline indole 1,2,3,4-tetrahydroquinoline quinoline and derivatives thereof
IL97807A0 (en) Process for preparing pyridine and quinoline derivatives
NO302416B1 (no) Fremgangsmåte for fremstilling av pergolid
NO881055L (no) Fremgangsmaate ved fremstilling av okso-isoindolinyl-derivater.
NO179909C (no) Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater
IL99900A0 (en) Quinoline derivatives,pharmaceutical compositions containing them and process for preparing same
NO953459D0 (no) Fremgangsmåte ved fremstilling av cykloheptimidazolderivater
NO921389D0 (no) Fremgangsmaate for fremstilling av kinolinderivater
NO881709D0 (no) Fremgangsmaate ved fremstilling av nye dihydropyridinderivater.